FDA Approves New Drug for Heavy Menstrual Bleeding
Save Email Print
Bookmark and Share
Posted: 4:58 PM Nov 13, 2009
FDA Approves New Drug for Heavy Menstrual Bleeding
Federal health officials have approved a new drug as the first non-hormonal treatment for heavy menstrual bleeding.
width:200 and height: 150 and picwidth: 200 and pciheight: 150
Font Size:

WASHINGTON (AP) - Federal health officials have approved a new drug as the first non-hormonal treatment for heavy menstrual bleeding.

The Food and Drug Administration says Lysteda tablets reduce bleeding by acting on a protein that helps blood clot. The drug is made by Newport, Ky.-based Xanodyne Pharmaceuticals.

The main ingredient in the drug was first approved in 1986 as an injection for patients with hemophilia, an inheritable disease that prevents blood clotting.

The FDA warns that taking Lysteda with hormonal contraceptive drugs can increase the risk of blood clots, stroke and heart attacks. Women should only use the products together if there is a strong medical need, the agency says.

(Copyright 2009 by The Associated Press. All Rights Reserved.)

4Warn Weatherfrom Touchstone Energy Cooperative
5day
5-DAY
temp
TEMPS
Interactive Radar
INTERACTIVE RADAR

Thursday Clouds through midday... Sunny at times in the afternoon... Chilly with ...More Details

Warnings & Watches | Text Alerts | Email Forecasts

In Remembrance...Deputy Don Williams
Moms Everyday
Valentines Day Contest
Where to Watch
  • WTVY
  • WTVY2
  • WTVY3
Connect with WTVY Text Alerts Mobile Site Desktop Alert Mobile Apps RSS Feeds Enews Twitter Facebook
Buddy Check 4
WTVY.com Features
Get the ingredients you need to cook with Rach all week long.
Today's Hits, Classics & Soaps. Don't miss an episode.
Full length exclusive concerts from hot artists.
Fitness Tips
Lose Weight, Get Fit with Michele
Take a break!
Classic Pacman, Frogger, Asteroids and more.
FREE Listings
Sell almost anything locally.
In Partnership with AL.com